These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 7799341

  • 1. Intermittent treatment with D-penicillamine is effective in lower doses and with fewer adverse effects in patients with rheumatoid arthritis.
    Hakoda M, Taniguchi A, Kamatani N, Akahoshi T, Kashiwazaki S.
    J Rheumatol; 1994 Sep; 21(9):1637-41. PubMed ID: 7799341
    [Abstract] [Full Text] [Related]

  • 2. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
    Clements PJ, Furst DE, Wong WK, Mayes M, White B, Wigley F, Weisman MH, Barr W, Moreland LW, Medsger TA, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner S, Andrews B, Abeles M, Seibold JR.
    Arthritis Rheum; 1999 Jun; 42(6):1194-203. PubMed ID: 10366112
    [Abstract] [Full Text] [Related]

  • 3. Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized, double blind, multicenter study.
    van Rijthoven AW, Dijkmans BA, Thè HS, Meijers KA, Montnor-Beckers ZL, Moolenburgh JD, Boers M, Cats A.
    J Rheumatol; 1991 Jun; 18(6):815-20. PubMed ID: 1895262
    [Abstract] [Full Text] [Related]

  • 4. Penicillamine in rheumatoid arthritis.
    Hill AG, Hill HF.
    Agents Actions Suppl; 1979 Jun; (5):129-38. PubMed ID: 393102
    [Abstract] [Full Text] [Related]

  • 5. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R, Schleusser B, Herborn G, Karger T.
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [Abstract] [Full Text] [Related]

  • 6. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
    J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
    [Abstract] [Full Text] [Related]

  • 7. Degree and extent of response to sulphasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two-year period.
    Capell HA, Marabani M, Madhok R, Torley H, Hunter JA.
    Q J Med; 1990 Apr; 75(276):335-44. PubMed ID: 1974723
    [Abstract] [Full Text] [Related]

  • 8. Combination D-penicillamine and methotrexate therapy: proposal for early and aggressive treatment for rheumatoid arthritis.
    Lee S, Solomon G.
    Bull Hosp Jt Dis Orthop Inst; 1990 Apr; 50(2):160-8. PubMed ID: 2175662
    [Abstract] [Full Text] [Related]

  • 9. [Current status of D-penicillamine therapy in chronic polyarthritis].
    Franke M, Menning H, Ströbel G.
    Z Rheumatol; 1981 Apr; 40(2):54-61. PubMed ID: 7282106
    [Abstract] [Full Text] [Related]

  • 10. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
    Luis M, Pacheco-Tena C, Cazarín-Barrientos J, Lino-Pérez L, Goycochea MV, Vazquez-Mellado J, Burgos-Vargas R.
    Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688
    [Abstract] [Full Text] [Related]

  • 11. The side effects of penicillamine therapy in rheumatoid arthritis.
    Huskisson EC.
    J Rheumatol Suppl; 1981 Oct; 7():146-8. PubMed ID: 6939876
    [Abstract] [Full Text] [Related]

  • 12. [Long term treatment of rheumatoid arthritis. Experiences with D-penicillamine in comparison with gold and immunosuppressive drugs (author's transl)].
    Warnatz H, Scheiffarth F, Gutmann W.
    Med Klin; 1975 Sep 19; 70(38):1509-15. PubMed ID: 810648
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
    Leonard PA, Bienz SR, Clegg DO, Ward JR.
    J Rheumatol; 1987 Feb 19; 14(1):55-9. PubMed ID: 3106632
    [Abstract] [Full Text] [Related]

  • 16. Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis.
    Verschueren P, Esselens G, Westhovens R.
    Rheumatology (Oxford); 2008 Jan 19; 47(1):59-64. PubMed ID: 18039681
    [Abstract] [Full Text] [Related]

  • 17. [Side effects of d-penicillamine in the treatment of rheumatoid arthritis].
    Mazzanti G, Paladini G, Damiani D, Bianchini D, Florean M, Mesesnel E, Cataldo R.
    Minerva Med; 1986 May 31; 77(22-23):1009-16. PubMed ID: 2941698
    [Abstract] [Full Text] [Related]

  • 18. [Comparative evaluation of the effectiveness of gold preparations and D-penicillamine and their tolerance in rheumatoid arthritis. I. The effect on the indicators of their activity and tolerance].
    Slobodina GA, Kanevskaia MZ, Krel' AA, Chichasova NV.
    Revmatologiia (Mosk); 1989 May 31; (1):8-16. PubMed ID: 2501852
    [Abstract] [Full Text] [Related]

  • 19. Effect of D-penicillamine on lymphocyte subsets: correlation with clinical response in rheumatoid arthritis.
    Singh RR, Malaviya AN, Malaviya R, Sharma M, Shandilya R, Taneja V, Khare SD, Beri D, Kumar A, Mehra NK.
    J Assoc Physicians India; 1994 Mar 31; 42(3):201-4. PubMed ID: 7860508
    [Abstract] [Full Text] [Related]

  • 20. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine.
    Redda A, Anastassiades T.
    Clin Invest Med; 1984 Mar 31; 7(1):65-71. PubMed ID: 6426836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.